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Simple Summary: Obesity contributes to one-fifth of cancer deaths. Ovarian cancer (OC) progression
is frequently asymptomatic, making its early detection difficult and its chance of survival low.
OC expresses highly tumorigenic chemokines, CXCL1/8, of which the specific receptor CXCR2 is
increased in the adipocytes. So, the CXCL1/8-CXCR2 axis may appear as a molecular link between
obesity and OC. Here, we generated adipocyte-specific CXCR2 conditional knockout (cKO) mice to
investigate how this CXCR2 cKO affects the peritoneal dissemination of OC under obese conditions.
High-fat, diet-induced obese mice had a shorter survival than lean mice. Particularly, obese cKO
mice had a reduced tumor burden but increased ascites accumulation, showing a decreased floating
tumor burden in ascites, as well as proliferation and macrophage infiltration in tumors compared to
obese wild-type mice. Despite the ascites accumulation, adipocyte-specific CXCR2 cKO reduced the
obesity-induced tumor burden, likely altering the peritoneal tumor microenvironment of OC.
Abstract: Obesity contributes to ovarian cancer (OC) progression via tumorigenic chemokines.
Adipocytes and OC cells highly express CXCR2, and its ligands CXCL1/8, respectively, indicating
that the CXCL1/8-CXCR2 axis is a molecular link between obesity and OC. Here, we investigated
how the adipocyte-specific CXCR2 conditional knockout (cKO) affected the peritoneal tumor mi-
croenvironment of OC in a high-fat diet (HFD)-induced obese mouse model. We first generated
adipocyte-specific CXCR2 cKO in mice: adipose tissues were not different in crown-like structures
and adipocyte size between the wild-type (WT) and cKO mice but expressed lower levels of CCL2/6
compared to the obese WT mice. HFD-induced obese mice had a shorter survival time than lean mice.
Particularly, obese WT and cKO mice developed higher tumors and ascites burdens, respectively. The
ascites from the obese cKO mice showed increased vacuole clumps but decreased the floating tumor
burden, tumor-attached macrophages, triglyceride, free fatty acid, CCL2, and TNF levels compared
to obese WT mice. A tumor analysis revealed that obese cKO mice attenuated inflammatory areas,
PCNA, and F4/80 compared to obese WT mice, indicating a reduced tumor burden, and there were
positive relationships between the ascites and tumor parameters. Taken together, the adipocyte-
specific CXCR2 cKO was associated with obesity-induced ascites despite a reduced tumor burden,
likely altering the peritoneal tumor microenvironment of OC.
Keywords: obesity; high-fat diet; CXCR2; ascites; ovarian cancer
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1. Introduction
Obesity, a disease defined by excessive fat accumulation which impairs health, is an
escalating global epidemic: according to the World Health Organization, there are predicted
to be 1.12 billion obese adults by 2030 [1]. Obesity is a known risk factor for many diseases,
such as diabetes, cardiovascular disease, and cancer [2]. Several types of cancers are related
to obesity, including cancers of the pancreas, corpus uteri (endometrium), esophagus,
rectum, kidney, liver, colon, gallbladder, breast, thyroid, and ovary [3]. Obesity contributes
to one-fifth of cancer deaths, with abnormal metabolism, chronic inflammation, growth
factor signaling, and angiogenesis being the primary drivers of obesity-related cancers [4,5].
The direct molecular factors linking obesity and cancer are not fully understood, but the
organ-dependent crosstalk between the adipose tissue and carcinomas via the vascular
endothelial growth factor (VEGF), interleukin 6 (IL-6), tumor necrosis factor α (TNFα), and
other mechanisms are implicated [6].
Among obesity-related cancers, ovarian cancer (OC) is the second leading cause of
gynecological cancer-related death in women worldwide [7]. The asymptomatic and rapid
progression of OC makes its early detection difficult, resulting in a low 5-year survival rate
of only 49.1% [8]. This low survival rate is also attributable to the frequent and aggressive
metastasis of OC throughout the peritoneal cavity, forming the secondary tumor foci and
ascites [9]. The accumulation of malignant ascites provides growth factors, fatty acids,
and chemokines to the OC cells, leading to a more aggressive and metastatic OC and
a poor prognosis [10,11]. Chemokines are recognized as critical mediators in the tumor
microenvironment and play a central role in regulating the inflammatory response, con-
tributing to the progression and metastasis of OC [12]. Specifically, chemokines, such as
CCL20, CXCL1–3, CXCL5, and CXCL8, are highly expressed in OC cells and the tumor
microenvironment of OC [13–15]. These proangiogenic and tumorigenic chemokines are
closely associated with the CXC chemokine receptor type 2 (CXCR2) [16–19]. CXCR2 is
highly expressed in tumors of some OC patients and may promote OC progression [15,17].
In addition, CXCR2-mediated signaling is involved in the tumorigenicity of OC [18,19].
Interestingly, mouse adipocytes expressed higher levels of CXCR2 mRNA compared to
preadipocytes [20] and OC progression could be accelerated by an obesity-induced in-
flammatory burden [21]. Based on the high expression levels of CXCL1–3 and CXCL8 in
OC cells [13,14] and the high levels of CXCR2 in adipocytes [20], the CXCL1/8-CXCR2
axis is proposed as a molecular link between obesity and OC. CXCR2 transfected OC
cells expressed higher levels of CXCL1/2 compared to CXCR2 null OC cells [19] and
obesity-induced, higher circulating CXCL1 levels [21], indicating a positive feedback loop.
CXCR2 knockout (KO) mice had a significantly reduced tumor burden in other cancers,
such as murine lung, prostate, and renal cancer models, compared to CXCR2 wild-type
(WT) mice [22–24]. These findings indicate that CXCR2 may be a critical molecular target
to attenuate the progression of OC. However, the global deletion of CXCR2 using KO mice
is not suitable for a diet-induced obesity model due to fewer and smaller adipocytes in
this KO mouse model [25]. Accordingly, we generated adipocyte-specific, CXCR2 condi-
tional knockout (cKO) mice for the first time to minimize the undesirable effects of CXCR2
deletion in other tissues, including immune cells. These CXCR2 cKO mice were employed
to clarify the roles of adipocyte-derived CXCR2 signaling in the peritoneal dissemination
of OC.
In this study, we investigated if adipocyte-specific CXCR2 cKO could modulate the
peritoneal dissemination of OC in a pseudo-postmenopausal, diet-induced obese mouse
model. We assessed the peritoneal tumor burden of OC under lean and obese states by
feeding a normal diet (ND) and a high-fat diet (HFD), respectively, in adipocyte-specific
CXCR2 cKO and WT mice.
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2. Materials and Methods
2.1. Generation of Adipocyte-Specific CXCR2 cKO Mice
We generated adipocyte-specific CXCR2 cKO mice with cre-lox technology by cross-
ing C57BL/6-Cxcr2tm1Rmra/J (JAX #024638) with B6.FVB-Tg (Adipoq-cre)1Evdr/J (JAX
#028020) under the cooperation of Jackson Laboratory (Bar Harbor, ME, USA). Homozy-
gous (CXCR2fl) females were used as WT counterpart mice (Figure 1A).
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ND-cKO, HFD-WT, and HFD-cKO mice. Red asterisks indicate crown-like structures and area measurement was calcu-
lated from 100 random adipocytes with ImageJ. (D) Comparison of crown-like structures in perigonadal adipose tissues 
from ND-WT, ND-cKO, HFD-WT, and HFD-cKO mice. Red circles mark crown-like structures; data were obtained from 
10 random fields under microscope. E) Comparison of chemokine/cytokine signature in perigonadal adipose tissues from 
ND-WT, ND-cKO, HFD-WT, and HFD-cKO mice by Proteome Profiler Mouse Chemokine Array (n = 3). Bars and error 
bars refer to mean and SEM. * and # indicates a significant increase and decrease (p ≤ 0.05), respectively, as determined by 
ANOVA and Tukey’s pairwise comparison. 
2.2. .Western Blots 
Adipose tissues were excised from ND-WT, ND-cKO, HFD-WT, and HFD-cKO mice, 
and homogenized in a radio-immunoprecipitation assay buffer with protease and phos-
phatase inhibitors (MilliporeSigma, St. Louis, MO, USA). The homogenized mixtures 
were centrifuged at 10,000 × g for 10 min at 4 °C and each clear supernatant, excluding the 
upper layer of lipid, was transferred to a new tube. After additional centrifugation under 
the same conditions, protein lysates were prepared. Total protein concentration for pro-
tein lysates was measured using the Bio-Rad protein assay based on the Bradford dye-
Figure 1. G neration of adipocyte-specific CXCR2 c i racteristics of adipose tissues in ND-WT, ND-cKO,
HFD-WT, and HFD-cKO mice. ( ) ti n of adipocyte-specific CXCR2 cKO mice by crossing C57BL/6-Cxcr2tm1Rmra/J
(JAX #024638) B6.FVB-Tg (Adipoq-cre)1Evdr/J (JAX #02802 ). (B) Confirmation of CXCR2 protein levels in perigonadal
adipose tissues from ND-WT, ND-cKO, HFD-WT, and HFD-cKO mice without tu ors. The image shown is repres ntative
of triplicate experiments. (C) Comparison of adipocyte size in perigonadal adipose tissues from ND-WT, ND-cKO, HFD-WT,
and HFD-cKO mice. Red asterisks indicate crown-like structures and area measurement was calculated fro 100 random
adipocytes with ImageJ. (D) Comparison of crown-like structures in perigonadal adipose tissues from ND-WT, ND-cKO,
HFD-WT, and HFD-cKO mice. Red circles mark crown-like structures; data were obtained from 10 random fields under
microscope. (E) Comparison of chemokine/cytokine signature in perigonadal adipose tissues from ND-WT, ND-cKO,
HFD-WT, and HFD-cKO mice by Proteome Profiler Mouse Chemokine Array (n = 3). Bars and error bars refer to mean and
SEM. * and # indicates a significant increase and decrease (p ≤ 0.05), respectively, as determined by ANOVA and Tukey’s
pairwise comparison.
.2. Western l ts
Adipose ti sues ere - T, ND-cKO, HFD-WT, and HFD-cKO mice,
and homogenized in a r i ci itation as ay buffer with protease and phos-
phatase inhibitors ( illi r i , St. is, O, USA). The homogenized mixtures
were centrifuged at 10,000 g for 10 min at 4 ◦C and each clear supernatant, excluding
the upper layer of lipid, was transferred to a new tube. After additional centrifugation
under the same conditions, protein lysates were prepared. Total protein concentration
for protein lysates was measured using the Bio-Rad protein assay based on the Bradford
dye-binding method (Bio-Rad, Hercules, CA, USA). The protein lysates were fractionated
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on SDS-polyacrylamide gels and transferred to polyvinylidene difluoride membranes ac-
cording to established procedures [19]. IL-8RB (K-19) antibody (Santa Cruz Biotechnology,
Santa Cruz, CA, USA) was used to detect CXCR2 protein levels. β-actin (C4) antibody
(Santa Cruz Biotechnology) served as an internal loading control. The targeted protein
bands were visualized by chemiluminescence detection kits (MilliporeSigma, St. Louis,
MO, USA).
2.3. Histological Analysis of Adipose Tissues
Perigonadal adipose samples from CXCR2 WT and cKO mice fed with ND and HFD
without tumors were fixed in neutral buffered formalin for 7 days and then processed for
paraffin embedding. Samples were sectioned at 5 µm and then processed for hematoxylin
and eosin (H&E) staining. Digital images of slides were captured with BZ-X700 All-in-One
Fluorescence Microscope (KEYENCE, Itasca, IL, USA). Adipocyte size was calculated as the
mean area of 100 random adipocytes in digital images with ImageJ. Crown-like structures
were counted from 10 random fields in microscopic images with 10× power fields.
2.4. Proteomic Array for Chemokine Signature
Chemokine signatures in adipose tissues and ascites were evaluated using Proteome
Profiler Mouse Chemokine Array (ARY020; R&D Systems, Minneapolis, MN, USA) accord-
ing to the manufacturer’s instructions as described previously [21]. Spot intensity of spots
was calculated with ImageJ by subtracting average background signals and normalizing
with reference spots.
2.5. Mouse Peritoneal Dissemination of OC in a Postmenopausal Obese Mouse Model
Mouse peritoneal dissemination of OC and diet-induced obesity at a pseudo-
postmenopausal state were performed under guidelines approved by the Institutional
Animal Care and Use Committee at Meharry Medical College (eProtocol#16-06-566) and
the National Institutes of Health (NIH) guide for the Care and Use of Laboratory Animals.
Six- to eight-week-old CXCR2 WT and cKO mice were ovariectomized (OVX) to create
a pseudo-postmenopausal state. The mice were maintained in a specific pathogen-free
animal housing facility at 22 ◦C ± 2 ◦C and 40–60% humidity under a 12:12 light: dark
cycle. The mice were maintained on ND (5% kcal from fat) and HFD (D12492; 60% kcal
from fat) obtained from Research Diets Inc. (New Brunswick, NJ, USA) for 16 weeks to
produce lean and obese mice, respectively. We grouped mice as follows: (1) ND-WT; (2)
HFD-WT; (3) ND-cKO; and (4) HFD-cKO. After confirming body weight gain in obese
mice, mouse ID8 OC cells (3 × 106 cells/mouse in a volume of 0.2 mL PBS) were injected
intraperitoneally into all mice. Along with weekly body weight, mice were monitored 3
times per week to assess animal health such as hunched posture, lethargy and inactivity,
impaired ambulation, shallow or labored breathing, hair coat condition, and change in the
body weight. Mice showing signs of increase in body weight due to tumors and changes in
appearance and activity were observed daily. When an increase of 20% in body weight,
extensive ascites accumulation, or sluggish activity were observed, animals were eutha-
nized for humane reasons. Tumors in the diaphragm, omentum, and pelvic sites were
investigated for spreading index and omental tumor tissues were served for histological
examination using H&E staining and immunohistochemistry with targeted antibodies. The
survival times of the mice were compared between each group.
2.6. Cellular Characteristics in OC-Induced Ascites
Ascites collected via intraperitoneal aspiration were immediately smeared on slides
and the slides were fixed in methanol and stained with Wright’s Giemsa stain. Ascitic
fluid was prepared by centrifuging at 1500 rpm for 5 min and stored in a −80 ◦C freezer
for further analysis. Digital images of slides were captured with BZ-X700 All-in-One
Fluorescence Microscope (KEYENCE, Itasca, IL, USA). Floating cells in OC-induced ascites
were quantitatively analyzed by calculating from 5 random fields of each slide using ImageJ
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for area measurement. Numbers of monocytes (Mo) and macrophages (Mϕ) in OC-induced
ascites were obtained from 5 random fields of each slide under microscope. Comparisons
of vacuole and non-vacuole clumps showing cytoplasmic lipid droplets were obtained
from 10 random fields of each slide under microscope.
2.7. Biochemical Analyses in OC-Induced Ascites
Triglyceride and free fatty acid levels in ascites were measured by EnzyChrom™
Triglyceride (ETGA-200) and Free Fatty Acid (EFFA-100) Assay Kits (BioAssay Systems,
Hayward, CA, USA) according to the manufacturer’s instructions. The optical density of
each well was determined using a microplate reader at 570 nm wavelength. Total protein
levels for ascites were measured using the Bio-Rad protein assay based on the Bradford
dye-binding method (Bio-Rad). Glucose levels in ascites were measured by Glucose
Colorimetric Assay Kit (Cayman Chemical, Ann Arbor, MI, USA). The absorbance of each
well was determined using a microplate reader at 514 nm wavelength. Vascular endothelial
growth factor (VEGF) levels in ascites were measured by Mouse VEGF Quantikine ELISA
Kit (MMV00; R&D Systems, Minneapolis, MN, USA) according to the manufacturer’s
instructions. The optical density of each well was determined using a microplate reader set
to 450 nm with wavelength correction of 570 nm. Tumor necrosis factor-α (TNFα) levels
in ascites were measured by Mouse TNFα enzyme-linked immunosorbent assay (ELISA)
kit (RAB0477; MilliporeSigma) according to the manufacturer’s instructions. The optical
density of each well was determined using a microplate reader at 450 nm wavelength.
2.8. Histological and Immunohistochemical Evaluation of Tumor Tissues
Omental tumor samples were analyzed using H&E stain and immunohistochemistry.
Paraffin slide sections were washed three times in xylenes followed by rehydration in a se-
ries of two alcohol washes (100% and 95%). Sections were treated for heat antigen retrieval
in EDTA solution (1 mM, pH 8.0). After blocked in goat serum, sections were incubated
overnight with specific primary antibodies as follows: PCNA (PC10) for proliferating cells,
F4/80 (D2S9R) for Mϕ, Arginase-1 (D4E3M) for MDSCs, CD4 (D7D2Z) for CD4 T cells, and
CD8α (D4W2Z) for CD8 T cells (Cell Signaling Tech., Danvers, MA, USA). Sections were
incubated with secondary antibody matched with primary antibody and developed using
SignalStain® DAB Substrate kit (#8059; Cell Signaling Tech.) with hematoxylin counterstain.
Digital images of slides were captured with BZ-X700 All-in-One Fluorescence Microscope
(KEYENCE). Quantitative analysis of inflammatory area in H&E stain was calculated using
ImageJ with selection of inflammatory area through color threshold followed by particles
analysis. Quantitative analysis of PCNA and immune cell dispositions was performed
using ImageJ with brown color selection through color deconvolution of hematoxylin and
3,3′-diaminobenzidine (DAB) staining followed by intensity analysis. Quantitative analysis
was obtained from 3–5 random fields of each slide (10×).
2.9. Statistical Analysis
Data values were expressed as the mean± the standard error of the mean (SEM). Data
were analyzed and compared using unpaired Student’s t-tests and one-way ANOVA as
appropriate. If statistical significance (p ≤ 0.05) was determined by ANOVA, the data were
further analyzed by Tukey’s pairwise comparison to detect specific differences between
treatment groups. R-squared values for correlations between continuous variables were
calculated from linear regression from the Data Analysis Tools in MS-Excel. Differences in
survival plots were evaluated with the log-rank test [26].
3. Results
3.1. Adipocyte-Specific CXCR2 cKO Mice Have Low Levels of CCL2/6 in Adipose Tissues
Compared to Those in CXCR2 WT Mice
CXCR2-mediated signaling was involved in the tumorigenicity of OC [18,19] and
adipogenesis [20]. An adipocyte-driven chemokine network appeared to involve CXCR2-
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mediated signaling [20,25,27], launching a tumorigenic burden of OC cells which expressed
high levels of CXCL1–3 and CXCL8 [13,14]. Accordingly, targeting CXCR2 may be crit-
ical in blocking the obesity-induced progression of OC. CXCR2 KO mice (C129S2(B6)-
Cxcr2tm1Mwm/J mice, Jackson Laboratory) were not susceptible to diet-induced obesity,
showing a lower weight gain. Thus, we first generated adipocyte-specific CXCR2 cKO mice
by crossing C57BL/6-Cxcr2tm1Rmra/J (JAX #024638) with B6.FVB-Tg (Adipoq-cre)1Evdr/J
(JAX #028020) (Figure 1A). All mice were ovariectomized to avoid the suppressive effects of
estrogen on obesity [28,29] and to create a pseudo-postmenopausal state, as most ovarian
cancers develop after menopause. Before the intraperitoneal injection of ID8 OC cells, we
confirmed the predominant expression levels of the CXCR2 protein in the adipose tissues
from ND- and HFD-fed WT mice, but little expression of CXCR2 in ND- and HFD-fed
cKO mice (Figures 1B and S1). The adipose tissues in HFD-fed WT mice showed a larger
increase in CXCR2 protein levels compared to ND-fed mice (Figure 1B), indicating an
obesity-induced CXCR2 expression. The adipocyte size showed an approximate 2-fold
increase in HFD-fed mice compared to ND-fed mice but there was no significant difference
between CXCR2 WT and cKO mice (Figure 1C). Crown-like structures in the adipose
tissues were not different between CXCR2 WT and cKO mice but there was an approxi-
mate 2-fold increase in both HFD-fed mice (Figure 1D), indicating the stimulation of the
proinflammatory processes in the adipose tissue due to obesity in HFD-fed mice. The
chemokine signatures in adipose tissues revealed the induction of high levels of CCL2 and
CCL6 proteins in HFD-fed WT mice, but not in HFD-fed cKO mice (Figures 1E and S2).
Interestingly, ND-fed WT and cKO mice showed low levels of chemerin and high levels
of IL-16 in the adipose tissues, respectively (Figure 1E). HFD-fed mice had low levels of
adipsin compared to ND-fed mice (Figure 1E). A decreased adipsin activity was observed
as a common feature of several experimental models of obesity [30], validating the burden
of obesity induced by HFD.
3.2. Obese CXCR2 WT Mice Have Greater Tumor Burdens, While Obese CXCR2 cKO Mice Have
Greater Ascites Burdens
There were no significant differences in body weight between WT and cKO mice at
the start of our experiments and in the body weight gain after ND and HFD conditions
(Figure 2A). The HFD-fed obese mice had approximately 2-fold higher body weights
compared to ND-fed lean mice. Although lean CXCR2 cKO mice had a decreasing trend
in body weight with an advanced tumor burden (from 9 weeks after OC cell injection),
this was not significant (Figure 2A). HFD-fed obese mice had a shorter survival than
ND-fed mice, regardless of the CXCR2 cKO in the adipose tissues, with outcomes of
117 ± 3.1 days in ND-WT, 102 ± 3.4 days in HFD-WT, 113 ± 4.5 days in ND-cKO, and
105 ± 2.9 days in HFD-cKO mice (Figure 2B). Although our results supported a shorter
survival in OC patients with obesity [31,32], adipocyte-specific CXCR2 cKO was not likely
to critically affect the survival of OC. The peritoneal dissemination of ID8 OC cells was
observed in all mice, spreading widely into the parietal and visceral peritoneum with a
solid tumor formation on the omentum (Figure 2C). The obese WT mice had increased
tumor weights compared to the lean mice, while obese cKO mice tended to have higher
tumor weights without statistical significance (Figure 2D). The spleen weights shared a
similar pattern (Figure 2E). Interestingly, obese cKO mice had a greater accumulation of
ascites in the peritoneal cavity compared to other groups (Figure 2F). This indicated that
adipocyte-specific CXCR2 cKO was related to the obesity-induced accumulation of ascites
in OC.
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each group. Comparison of (D) tumor weight, (E) spleen weight, and (F) ascites volumes in ND-WT (n = 8 for ascites and
14 for tumor and spleen), ND-cKO (n = 6 for ascites, 10 for tumor, and 9 for spleen), HFD-WT (n = 8 for ascites and 11 for
tumor and spleen), and HFD-cKO (n = 7 for all parameters) mice. * indicates a significant difference (p ≤ 0.05) between
groups as analyzed by ANOVA and Tukey’s pairwise comparison tests.
3.3. Adipocyte-Specific CXCR2 cKO Mice Have Lower Floating Tumor Burdens and
Tumor-Attached Monocytes/Macrophages but Increased Vacuole Clumps in OC-Induced Ascites
after Diet-Induced Obesity
Because obese CXCR2 cKO mice had greater ascites burdens (Figure 2F), we performed
ascitic analysis using ascites smeared with Wright’s Giemsa stain. The floating cells in the
OC-induced ascites were categorized from large to small areas in the following order: HFD-
WT > HFD-cKO > ND-WT > ND-cKO mice (Figure 3A). We observed the morphological
patterns of floating tumor cells in OC-induced ascites as follows: intact floating tumor cells,
Mo- and Mϕ-attached floating tumor cells, dispersed floating tumor cells with immune
cells, and small clumps of floating tumor cells attached with Mo/Mϕ (Figure 3(B1–4)).
Supposedly, the tumor cells floating without the attached immune cells seemed to be
detached from the original tumor sites just before the immune cells attached to the tumor
clumps (Figure 3(B1)). Immune cells, such as Mo and Mϕ seemed to approach to tumor
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clumps in order to attack (Figure 3(B2)). Mo and Mϕ attached to the tumor cells which
seemed to disperse tumor clumps, impeding the tight attachment between tumor cells
(Figure 3(B3)). Finally, the dispersed small tumor clumps seemed to be further attacked by
immune cells, such as Mo and Mϕ (Figure 3(B4)). We also observed some morphological
patterns between immune and tumor cells in OC-induced ascites. Few lymphocytes and
Mo were floating in the ascites (Figure 3C). Signet, ring-like cells containing cytoplasmic
vacuoles were observed in HFD-fed mice but were rare in ND-fed mice (Figure 3C). The
distribution of Mo and Mϕ in OC-induced ascites descended in the following order: HFD-
WT > HFD-cKO > ND-WT > ND-cKO mice (Figure 3D), being consistent with the floating
tumor cells (Figure 3A). Almost all Mo and Mϕ in the OC-induced ascites were attached
to tumor clumps but small numbers of them were floating in the ascites. Vacuole clumps
showing cytoplasmic lipid droplets in the OC-induced ascites were frequently observed in
HFD-fed mice but very rarely in ND-fed mice, demonstrating their higher levels in obese
CXCR2 cKO mice (Figure 3E).
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with ImageJ. (B) Morphological patterns of floating tumor cells in OC-induced ascites. B1: intact floating tumor cells; B2:
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3.4. Ascites in Obese CXCR2 cKO Mice Showed Low r Levels of Triglycerides, Free Fatty Acids,
CCL2, and TNF Compared to Those in Obese WT Mice
The ascites from HFD-fed CXCR2 WT mice had high levels of triglycerides and free
fatty acids (Figure 4A,B). Although the ascites from the ND-fed cKO mice showed high
levels of triglycerides and free fatty acids compared to those from ND-fed WT mice, HFD
was unable to significantly increase these levels in the OC-induced ascites of CXCR2
cKO mice (Figure 4A,B). Consequently, we evaluated if adipocyte-specific CXCR2 cKO
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influenced the chemokine signatures in OC-induced ascites using proteomic arrays. Al-
though OC-induced ascites contained high levels of CCL6, CCL8, CCL9/10, CXCL12, and
CXCL16, these chemokines showed no significant difference between obese and lean mice
or between WT and cKO mice (Figures 4C,D and S3). Interestingly, CCL2 protein levels
were significantly higher in obese WT mice compared to those in all the other groups
(Figure 4C,D). Although obese WT mice tended to show higher protein levels of CXCL1,
CXCL2, CXCL5, and CXCL10 (Figure 4D), there were no statistical differences between
groups. The total protein amount in ascites was similar between groups (Figure 4E), indi-
cating that the reduced levels of CCL2 in the ascites of obese cKO mice were not due to
differences in volume or dilution. The levels of glucose and VEGF in OC-induced ascites
had no significant differences between the groups (Figure 4F,G), while obese cKO mice
showed lower levels of secreted TNFα compared to those in obese WT mice (Figure 4H).
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3.5. Obese CXCR2 cKO Mice Show Attenuated Inflammatory Area, PCNA, and F4/80 in Tumor
Tissues Compared to Obese WT Mice
We evaluated the histological features of omental tumor tissues as a frequent site
of OC in the peritoneal cavity. Both obese CXCR2 WT and cKO mice had larger and
more abundant adipocytes in the omental tumor tissues compared to those in lean mice
(Figure 5A). Particularly, the regions between the adipose and tumor tissues showed
evidence of an inflammatory reaction as shown by the recruited immune cells; this was
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greater in HFD-fed WT mice compared to other groups (Figure 5A). Because proliferating
the cell nuclear antigen (PCNA) was a universal marker of proliferating cells, we evaluated
PCNA positive cells in omental tumor tissues. Most PCNA positive cells appeared at
the edges of tumor tissues to rapidly develop tumor growth and regions between the
adipose and tumor tissues (Figure 5B). A quantitative analysis of the PCNA disposition
revealed that HFD-fed WT mice had greater PCNA-positive cells compared to other groups
(Figure 5B).
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between CXCR2 WT and cKO mice. (A) Histological features of omental tumors in ND-WT, ND-cKO, HFD-WT, and HFD-
cKO mice using H&E stain. tm: tumor tissue, ft: fat tissue, if: inflammatory region. Quantitative analysis of inflammatory
area was performed using ImageJ with selection of inflammatory area through color threshold followed by particles analysis.
(B) Disposition of PCNA positive cells in omental tumors from ND-WT, ND-cKO, HFD-WT, and HFD-cKO mice using
immunohist chemistry. Qua titative analysis of PCNA disposition was perform using ImageJ with brown color selection
through color deconvolution of hematoxylin and DAB staining followed by i tensity analysis. Quantitative analysis wa
obtained from 3–5 random fields of each slide (10×). * indicates a significant difference (p ≤ 0.05) between groups as
analyzed by ANOVA and Tukey’s pairwise comparison tests.
Because tu or i filtrat g immu e cells were associa ed with clinical outcomes, we
evaluated the immune cell infiltrati in omental tumor tissues. F4/80, as a major Mϕ
m rker, appeared inten vely in regions between the fat and tumor tissues. A quantita
analysis of F4/80 disposition revealed that HFD-fed WT mice had greater F4/80-positive
cells compared to t e other gr ups (Figure 6A). Th myeloid-deriv d suppre sor cells
(MDSCs) expressed high l vels of arginase-1 an were recruited to the tumor tissues [33].
M st arginase-1 positive cells appeared at the edges of the tumor tissues to trigger tumor
growth and in the regions between the adipose and tumor tissues. A quantitative analysis
of arginase-1 disposition showed no significant difference between the groups (Figure 6B).
Most CD4-positive cells appeared in the inflammatory regions between the adipose and
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tumor tissues, with no significant differences between the groups in the CD4 disposition
(Figure 6C). Similar to the CD4 disposition, most of the CD8-positive cells also appeared
in the inflammatory regions between the fat and tumor tissues, showing no significant
difference between the groups in the CD8 disposition (Figure 6D).
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(D) CD8-positive cells in omental tumors from ND-WT, ND-cKO, HFD-WT, and HFD-cKO mice. Quantitative analysis of 
immune cell disposition was performed using ImageJ with brown color selection through color deconvolution of hema-
toxylin and DAB staining followed by intensity analysis. Quantitative analysis was obtained from 3–5 random fields of 
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3.6. CXCR2 cKO Mice Showed a Higher Positive Relationship between Ascites and Tumor Pa-
rameters Compared to WT Mice 
Because obese CXCR2 WT and cKO mice had greater tumor weights and ascites ac-
cumulation (Figure 2D,F), respectively, we evaluated the correlations between the tumor 
weights, spleen weights, ascites accumulation, and survival between CXCR2 WT and cKO 
mice. CXCR2 WT mice had a higher correlation between the tumor and spleen weights 
(R2 = 0.47) than between the tumor weights and ascites (R2 = 0.06). On the contrary, the 
CXCR2 cKO mice had a higher correlation between the tumor weights and ascites (R2 = 
Figure 6. Immunohistochemical evaluation of immune cells in omental tumor tissues from a postmenopausal diet-induced
obese mouse model between CXCR2 WT and cKO mice. Histological features of (A) F4/80-, (B) arginase-1-, (C) CD4-, and
(D) CD8-positive cells in omental tumors from ND-WT, ND-cKO, HFD-WT, and HFD-cKO mice. Quantitative analysis
of immune cell disposition was performed using ImageJ with brown color selection through color deconvolution of
hematoxylin and DAB staining followed by intensity analysis. Quantitative analysis was obtained from 3–5 random fields
of each slide (10×). * indicates a significant difference (p ≤ 0.05) between groups as analyzed by ANOVA and Tukey’s
pairwise comparison tests.
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3.6. CXCR2 cKO Mice Showed a Higher Positive Relationship between Ascites and Tumor
Parameters Compared to WT Mice
Because obese CXCR2 WT and cKO mice had greater tumor weights and ascites
accumulation (Figure 2D,F), respectively, we evaluated the correlations between the tu-
mor weights, spleen weights, ascites accumulation, and survival between CXCR2 WT
and cKO mice. CXCR2 WT mice had a higher correlation between the tumor and spleen
weights (R2 = 0.47) than between the tumor weights and ascites (R2 = 0.06). On the contrary,
the CXCR2 cKO mice had a higher correlation between the tumor weights and ascites
(R2 = 0.50) than between the tumor and spleen weights (R2 = 0.01) (Figure 7A,B). Further-
more, CXCR2 cKO mice had a higher correlation between the spleen weights and ascites
(R2 = 0.70) than WT mice (R2 = 0.06) (Figure 7C). With regard to survival, CXCR2 WT
mice had a higher correlation with the tumor weights (R2 = 0.22) than with spleen weights
(R2 = 0.06) and ascites (R2 = 0.001) (Figure 7D,F), whereas CXCR2 cKO mice had similar
correlations with the tumor weights (R2 = 0.14), spleen weights (R2 = 0.18), and ascites
(R2 = 0.16), demonstrating survival durations which lasted days (Figure 7D,F). These corre-
lation results suggested that the tumor and ascites burdens may be critical for the survival
of CXCR2 WT and cKO mice, respectively.
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inducing diet conditions. On the contrary, CXCR2 WT mice seemed to have a higher tumor
burden rather than an ascites burden from OC under obese conditions.
The crown-like structures in the adipose tissues indicated the adipose microenviron-
ments of Mϕ engulfing adipocytes, and their densities were usually higher in obese mice
than in lean mice [34]. Because HFD-fed mice increased the crown-like structures com-
pared to ND-fed mice without any change between CXCR2 WT and cKO mice (Figure 1C),
adipocyte-specific CXCR2 cKO was unlikely to critically affect adipose tissue inflammation
under obese conditions. The average size of adipocytes was larger in obese mice than in
lean mice [35]. Consistent with the results, HFD-fed mice in our study showed an increased
adipocyte size compared to that in ND-fed mice, but no difference between the CXCR2 WT
and cKO mice (Figure 1D). Female CXCR2 KO mice had a thinner subcutaneous adipose
layer due to fewer and smaller adipocytes, which was not observed in male mice [25]. In
contrast to the systemic CXCR2 KO, the adipocyte-specific CXCR2 cKO may not critically
affect adipose morphology. On the other hand, the obese CXCR2 cKO mice had low levels
of CCL2/6 in the adipose tissues compared to obese WT mice (Figure 1E). The adipocytes
produced CCL2 which was correlated with body mass index (BMI), whereas weight loss
reduced CCL2 levels [36]. Surgery-induced weight loss also reduced urinary CCL2 lev-
els [37]. Adipogenesis in mouse 3T3-L1 cells indicated CCL6 as a dominant chemokine
in mouse adipocytes [20]. These reports supported the HFD-induced CCL2/6 levels in
adipose tissues. Although CXCR2 cKO mice showed a normal adipose morphology, the
adipocyte-specific CXCR2 cKO may have affected the adipose microenvironment by dis-
rupting the adipose CCL2/6 levels in response to HFD. The CXCR2 cKO mice showed a
similar weight trend with WT mice in response to ND and HFD (Figure 2A), supporting
the similar results of crown-like structures and adipocyte size in adipose tissues between
WT and cKO mice (Figure 1C,D).
As obesity increases the risk of OC progression and leads to enhanced tumor bur-
den [38], HFD-induced obesity resulted in a shorter survival regardless of the CXCR2
in adipose tissues (Figure 2B). A shorter survival may be due to a greater tumor and
ascites burden in the HFD-fed CXCR2 WT and cKO, respectively (Figure 2D,F). These
results indicate that CXCR2-mediated signaling is involved in increased tumor burden in
the tumor microenvironment of OC by interacting with adipose tissues. Although obese
mice had a greater tumor burden compared to lean mice, the ascites accumulation was
unchanged [21]. Because the increased OC-induced ascites in HFD-fed CXCR2 cKO mice
(Figure 2F) was unexpected, we further analyzed the cellular and biochemical character-
istics of ascites. Consistently, as ascites in ob/ob mice had higher levels of Mϕ than lean
mice [21], the HFD-fed CXCR2 WT mice demonstrated dominant floating tumor burdens
and tumor-attached Mo/Mϕ in OC-induced ascites. On the other hand, ascites in HFD-fed
cKO mice attenuated the floating tumor burdens and tumor-attached Mo/Mϕ compared
to HFD-fed WT mice (Figure 3A,D). Even ND-fed cKO mice reduced these parameters in
OC-induced ascites compared to ND-fed WT mice (Figure 3A,D). These results confirmed
that the adipocyte-specific CXCR2 cKO attenuated the tumor burden of OC in response to
HFD. CXCR2 KO mice also had a reduced tumor volume after the injection with breast
cancer cells [39], supporting the attenuated tumor burdens in adipocyte-specific CXCR2
cKO mice. Interestingly, HFD-fed CXCR2 cKO mice showed increased cytoplasmic lipid
droplets of cell clumps in the OC-induced ascites (Figure 3E). The relationship between the
increased vacuole clumps and ascites volume was unclear at this point, requiring further
study. The increased vacuole clumps may be associated with lower levels of triglycerides
and free fatty acids as observed more in the OC-induced ascites of cKO mice than in
WT mice (Figure 4A,B), forming further vacuole clumps to reduce the amount of fat in
the ascites. On the other hand, the ascites of ND-fed cKO mice showed higher levels of
triglycerides and free fatty acids compared to that of ND-fed WT mice (Figure 4A,B). These
increased levels may be in part associated with decreased Mϕ in ascites of ND-fed cKO
mice (Figure 4D) because Mϕ could accumulate lipids via phagocytosis. VEGF was a
permeability factor for endothelial cells to play a role in angiogenesis [40]. Because VEGF
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levels in ascites was similar between WT and cKO mice (Figure 4G), VEGF was unlikely
to be a factor for the OC-induced ascites in CXCR2 cKO mice. CXCR2-deficient mice had
reduced the blood–brain barrier permeability in viral encephalitis [41] but the permeability
was not affected by closed head injury [42], indicating a disease-specific response.
Among chemokine signatures in OC-induced ascites, CCL2 had a significantly higher
expression in HFD-fed WT mice (Figure 4C,D), indicating that CCL2 may be an important
player in the peritoneal microenvironment of OC under obese conditions. CCL2 is known
to be markedly increased in obesity, with roles in Mo recruitment [43]. Our previous results
also showed high levels of CCL2 in ob/ob mice with leptin deficiency [21]. On the other
hand, HFD-fed CXCR2 cKO mice had lower levels of secreted TNFα compared to obese
WT mice (Figure 4H). TNFαwas shown to be significantly upregulated in ovarian tumor
tissues, leading to NF-κB activation [44]. Because CCL2, CXCL1, CXCL2, CXCL5, and
CXCL10 were upregulated by NF-κB signaling [14,45,46], TNFα-induced NF-κB activation
may have contributed to the increased tendencies of these chemokines in HFD-fed WT mice
(Figure 4D). Glioblastoma cell-secreted CXCL8 induced brain endothelial cell permeability
via CXCR2 [47]. As the mice lacked IL8/CXCL8, the murine homologues for human
CXCL8 were considered to be CXCL1–2 and CXCL5, as CXCR2 ligands [48]. Because
CXCL1–2 and CXCL5 levels showed a decreased tendency in ascites of HFD-fed CXCR2
cKO mice, compared to the WT mice (Figure 4D), these chemokines were unlikely to
contribute to OC-induced ascites in HFD-fed CXCR2 cKO mice. CCL2 secreted from
cancer-associated mesothelial cells could promote the malignant potential of OC, playing a
crucial role in the tumor microenvironment of OC [49]. However, the increased ovarian
tumoral expression of CCL2 was associated with an improved response to chemotherapy
and survival outcomes [50]. Despite the controversial effects of CCL2 in OC, the CCL2-
CCR2 axis was recognized as a critical player in recruiting tumor-associated Mϕ and
facilitating the progression of cancer [51], indicating further promoting effects due to
obesity. Although ID8 OC cells constitutively expressed CCL2 [46], adipocyte-conditioned
media had no effects on CCL2 but instead induced CXCL1, CXCL2, and CXCL10 in ID8
cells [21]. Therefore, the higher levels of CCL2 in the ascites of obese WT mice may be
derived not from tumoral tissues but from obesity-related, extra-tumoral tissues including
adipocytes, as observed in adipose tissues (Figure 1E). Although showing a similar weight
gain (Figure 2A) and similar distribution pattern of body fat (Figure 2C) with WT mice,
obese CXCR2 cKO mice showed lower levels of triglyceride, FFA, CCL2, and Mϕ in ascites
compared to obese WT mice (Figure 4). These results indicated that CXCR2 cKO obesity
critically responded to a pathological state rather than a physiological state. As a future
research direction, the quantitative analysis of physiological aspects, such as the food
intake pattern, fat distribution, and lipid metabolism, may give an important insight to
clarify the underlying mechanisms affecting the roles of CXCR2 in obesity.
The tumor tissues in HFD-fed CXCR2 cKO mice had lower inflammatory areas and
PCNA and F4/80 expressions, compared to those in HFD-fed WT mice (Figures 5 and 6A),
indicating a reduced tumor burden. These facts indicated that CXCR2-mediated signaling
was involved in tumor burden, showing immune cell infiltration in the tumor microen-
vironment. Consistently, systemic CXCR2 KO mice decreased PCNA and F4/80 tumor
associated Mϕ in mammary tumors [39]. CXCR2 KO mice also suppressed acute and
chronic pancreatic inflammation [52]. While CXCR2 KO mice decreased MDSCs in breast
tumors [39], adipose-specific CXCR2 cKO mice had no change in omental tumor tissues of
OC (Figure 6B). Particularly, the regions between the fat and tumor tissues were the main
target areas for immune cell infiltration, indicating the immune cell-mediated interaction
between the adipocytes and cancer cells followed by the higher potentiation of PCNA and
F4/80-positive cells under obese conditions. In addition, based on the correlation results
(Figure 7), CXCR2 WT and cKO mice could favorably induce tumor and ascites burdens,
respectively, playing a critical role in OC survival.
We summarized how adipocyte-specific CXCR2 cKO affected the peritoneal dissemi-
nation of OC under HFD-induced obese models based on our current results (Figure 8).
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As CCL2 is known to function in Mo/Mϕ recruitment [43], the high levels of CCL2 in the
adipose tissues and OC-induced ascites of HFD-fed WT mice could contribute to increased
Mo/Mϕ in the ascites and omental tumors. Overall, obese CXCR2 WT mice were likely
prone to drive OC progression through tumor growth, while obese cKO mice favored
ascites accumulation, which required further study to identify the molecular mechanisms.




Figure 8. Schematic for HFD-induced obese effects of adipocyte-specific CXCR2 cKO on the peritoneal tumor microenvi-
ronment of OC. Adipose tissues express high levels of CCL2/6 in obese WT mice compared to those in obese cKO mice. 
Interestingly, obese CXCR2 WT and cKO mice appear to have greater tumor and ascites burdens, respectively. Compared 
to obese CXCR2 WT mice, the cKO mice had lower ascitic floating tumor burdens and tumor-attached Mo/Mφ, less tri-
glyceride, free fatty acid, CCL2, and TNF levels, but increased vacuole clumps in OC-induced ascites. Obese CXCR2 WT 
mice had more inflammatory areas and PCNA- and F4/80-positive cells in tumor tissues compared to obese cKO mice. 
HFD-induced obesity leads to a shorter survival time compared to lean mice, regardless of CXCR2 status in adipose tis-
sues. Therefore, adipocyte-specific CXCR2 cKO is associated with ascites accumulation under obese conditions, instead of 
tumor burden as shown in obese CXCR2 WT mice, most likely altering the peritoneal tumor microenvironment of OC. 
Red and blue letters indicate increases and decreases, respectively. 
5. Conclusions 
In this study, we investigated how adipocyte-specific CXCR2 cKO affects the perito-
neal tumor microenvironment of OC in an HFD-induced obese mouse model. Adipocyte-
specific CXCR2 cKO mice fed with HFD had lower tumor burdens, inflammatory areas, 
proliferation markers, and Mφ infiltration compared to HFD-fed WT mice. However, 
obese CXCR2 cKO mice had a greater OC-induced ascites accumulation, showing reduced 
ascitic floating tumor cells and tumor-attached Mo/Mφ with lower triglyceride, free fatty 
acid, CCL2, and TNF levels compared to obese WT mice. Ascites in obese cKO mice had 
more vacuole clumps and a positive relationship with tumor and spleen weights. There-
fore, adipocyte-specific CXCR2 WT and cKO were associated with tumor and ascites bur-
dens, respectively, such that the loss of CXCR2 in adipocytes altered the peritoneal tumor 
microenvironment of OC. 
Author Contributions: Conceptualization, D.-S.S.; data curation, D.C., E.-S.L., A.B.F., A.J.W., 
M.M.W., S.E.A. and D.-S.S.; formal analysis, D.C., E.-S.L. and D.-S.S.; funding acquisition, E.-S.L., 
A.B.F., M.M.W., S.E.A. and D.-S.S.; investigation, D.C. and D.-S.S.; methodology, D.C., E.-S.L. and 
D.-S.S.; supervision, D.-S.S.; validation, D.C., E.-S.L., M.M.W. and D.-S.S.; visualization, D.-S.S.; 
writing—original draft preparation, D.C. and D.-S.S.; writing—review and editing, D.C., E.-S.L., 
A.B.F., A.J.W., M.M.W., S.E.A. and D.-S.S. All authors have read and agreed to the published version 
of the manuscript. 
Funding: This research was funded, in whole or in part, by National Institutes of Health (NIH) as 
the following grants: R01ES024756 (E.-S.L.), R01ES031282 (E.-S.L.), NIAID SC1AI089073 (D.-S.S.), 
NCI SC1CA200519 (D.-S.S.), U54MD007586 (S.E.A.) and U54CA163069 (D.-S.S., A.B.F., M.M.W., 
S.E.A.). 
Institutional Review Board Statement: The study was performed under guidelines approved by 
the Institutional Animal Care and Use Committee at Meharry Medical College (eProtocol#16-06-
566) and the National Institutes of Health (NIH) guide for the Care and Use of Laboratory Animals. 
Informed Consent Statement: Not applicable. 
Data Availability Statement: Not applicable. 
Figure 8. Schematic for HFD-induced obese effects of adipocyte-specific CXCR2 cKO on the peritoneal
tumor microenvironment of OC. Adipose tissues express high levels of CCL2/6 in obe e WT mice
compared to those in obese cKO mice. Inte stingly, obese CXCR2 WT and cKO mice appear to
have greater tumor and ascites burdens, respectively. Compared to obese CXCR2 WT mice, the
cKO mice had lower ascitic floating tumor burdens and tumor-attached Mo/Mϕ, less triglyceride,
free fatty acid, CCL2, and TNF levels, but increased vacuole clumps in OC-induced ascites. Obese
CXCR2 WT mice had more inflammatory areas and PCNA- and F4/80-positive cells in tumor tissues
compared to obese cKO mice. HFD-induced obesity leads to a shorter survival time compared to
lean mice, regardless of CXCR2 status in adipose tissues. Therefore, adipocyte-specific CXCR2 cKO
is associated with ascites accumulation under obese conditions, instead of tumor burden as shown in
obese CXCR2 WT mice, most likely altering the peritoneal tumor microenvironment of OC. Red and
blue letters indicate increases and decreases, respectively.
5. Conclusions
In this study, we investigated how adipocyte-specific CXCR2 cKO affects the peritoneal
tumor microenvironment of OC in an HFD-induced obese mouse model. Adipocyte-
specific CX R2 cKO mice fed with HFD had lower tumor burdens, inflammatory areas,
proliferation markers, and Mϕ infiltration compared to HFD-fed WT mice. However,
obese CXCR2 cKO mice had a greater OC-induced ascites accumulation, showing reduced
ascitic floating tumor cells and tumor-attached Mo/Mϕwith lower triglyceride, free fatty
acid, CCL2, and TNF levels compared to obese WT mice. Ascites in obese cKO mice
h d more vacuole clumps and a positive elationship with tu or and ple n weight .
Therefore, adipocyte-specific CXCR2 WT and cKO were associated with tumor and ascites
burdens, respectively, such that the loss of CXCR2 in adipocytes altered the peritoneal
tumor microenvironment of OC.
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